squiffy2
09-06-2007, 01:01 PM
Pipex Pharmaceuticals Announces Broadly Issued European Patent Covering Uses of Oral TRIMESTA for the Treatment of Autoimmune Diseases, Including Multiple Sclerosis.
Claims Covering Use of Estrogens Including TRIMESTA, in Combination With Popular Immunotherapies to Treat Multiple Sclerosis.
Pipex Pharmaceuticals, Inc, a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that it has received a broadly issued European patent which covers the use of estrogens in combination with other FDA-approved multiple sclerosis therapies for the treatment of autoimmune diseases.............
For the full article please go to MSRC: MS Research News : Drugs : Trimesta (Oral Estriol) (http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1878&CFID=419916&CFTOKEN=57563484)
Claims Covering Use of Estrogens Including TRIMESTA, in Combination With Popular Immunotherapies to Treat Multiple Sclerosis.
Pipex Pharmaceuticals, Inc, a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that it has received a broadly issued European patent which covers the use of estrogens in combination with other FDA-approved multiple sclerosis therapies for the treatment of autoimmune diseases.............
For the full article please go to MSRC: MS Research News : Drugs : Trimesta (Oral Estriol) (http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1878&CFID=419916&CFTOKEN=57563484)